Johnson & Johnson Showcases TECNIS PureSee IOL Data
Jacksonville, Florida | April 10, 2026 Johnson & Johnson has presented new clinical data for its TECNIS PureSee⢠intraocular...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Jacksonville, Florida | April 10, 2026 Johnson & Johnson has presented new clinical data for its TECNIS PureSee⢠intraocular...
LAKE FOREST, CALIFORNIA, UNITED STATES ā February 17, 2026 STAAR Surgical announced that the U.S. Food and Drug Administration...
